Global Cholera Vaccines Market Size, Status and Forecast 2020-2026

May 2020 | 94 pages | ID: GC41C328F7ECEN
QYResearch

Abstracts

This report focuses on the global Cholera Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cholera Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Shantha Biotechnics Private Limited
• PaxVax, Inc.
• Valneva SE
• Merck and Co., Inc.
• GlaxoSmithKline plc (GSK)
• Astellas Pharma, Inc.
• Pfizer, Inc.
• Emergent BioSolutions, Inc.
• Mitsubishi Tanabe Pharma Corporation
• Takeda Pharmaceutical Co., Ltd.

Market segment by Type, the product can be split into

• Dukoral
• Shanchol
• Vaxchora
• Others

Market segment by Application, split into

• Oral
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cholera Vaccines status, future forecast, growth opportunity, key market and key players.
• To present the Cholera Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cholera Vaccines are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cholera Vaccines Revenue
1.4 Market Analysis by Type
  1.4.1 Global Cholera Vaccines Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Dukoral
  1.4.3 Shanchol
  1.4.4 Vaxchora
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Cholera Vaccines Market Share by Application: 2020 VS 2026
  1.5.2 Oral
  1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cholera Vaccines Market Perspective (2015-2026)
2.2 Cholera Vaccines Growth Trends by Regions
  2.2.1 Cholera Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cholera Vaccines Historic Market Share by Regions (2015-2020)
  2.2.3 Cholera Vaccines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cholera Vaccines Market Growth Strategy
  2.3.6 Primary Interviews with Key Cholera Vaccines Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cholera Vaccines Players by Market Size
  3.1.1 Global Top Cholera Vaccines Players by Revenue (2015-2020)
  3.1.2 Global Cholera Vaccines Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cholera Vaccines Market Concentration Ratio
  3.2.1 Global Cholera Vaccines Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cholera Vaccines Revenue in 2019
3.3 Cholera Vaccines Key Players Head office and Area Served
3.4 Key Players Cholera Vaccines Product Solution and Service
3.5 Date of Enter into Cholera Vaccines Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cholera Vaccines Historic Market Size by Type (2015-2020)
4.2 Global Cholera Vaccines Forecasted Market Size by Type (2021-2026)

5 CHOLERA VACCINES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cholera Vaccines Market Size by Application (2015-2020)
5.2 Global Cholera Vaccines Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cholera Vaccines Market Size (2015-2020)
6.2 Cholera Vaccines Key Players in North America (2019-2020)
6.3 North America Cholera Vaccines Market Size by Type (2015-2020)
6.4 North America Cholera Vaccines Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cholera Vaccines Market Size (2015-2020)
7.2 Cholera Vaccines Key Players in Europe (2019-2020)
7.3 Europe Cholera Vaccines Market Size by Type (2015-2020)
7.4 Europe Cholera Vaccines Market Size by Application (2015-2020)

8 CHINA

8.1 China Cholera Vaccines Market Size (2015-2020)
8.2 Cholera Vaccines Key Players in China (2019-2020)
8.3 China Cholera Vaccines Market Size by Type (2015-2020)
8.4 China Cholera Vaccines Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cholera Vaccines Market Size (2015-2020)
9.2 Cholera Vaccines Key Players in Japan (2019-2020)
9.3 Japan Cholera Vaccines Market Size by Type (2015-2020)
9.4 Japan Cholera Vaccines Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cholera Vaccines Market Size (2015-2020)
10.2 Cholera Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cholera Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia Cholera Vaccines Market Size by Application (2015-2020)

11 INDIA

11.1 India Cholera Vaccines Market Size (2015-2020)
11.2 Cholera Vaccines Key Players in India (2019-2020)
11.3 India Cholera Vaccines Market Size by Type (2015-2020)
11.4 India Cholera Vaccines Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cholera Vaccines Market Size (2015-2020)
12.2 Cholera Vaccines Key Players in Central & South America (2019-2020)
12.3 Central & South America Cholera Vaccines Market Size by Type (2015-2020)
12.4 Central & South America Cholera Vaccines Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Shantha Biotechnics Private Limited
  13.1.1 Shantha Biotechnics Private Limited Company Details
  13.1.2 Shantha Biotechnics Private Limited Business Overview and Its Total Revenue
  13.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Introduction
  13.1.4 Shantha Biotechnics Private Limited Revenue in Cholera Vaccines Business (2015-2020))
  13.1.5 Shantha Biotechnics Private Limited Recent Development
13.2 PaxVax, Inc.
  13.2.1 PaxVax, Inc. Company Details
  13.2.2 PaxVax, Inc. Business Overview and Its Total Revenue
  13.2.3 PaxVax, Inc. Cholera Vaccines Introduction
  13.2.4 PaxVax, Inc. Revenue in Cholera Vaccines Business (2015-2020)
  13.2.5 PaxVax, Inc. Recent Development
13.3 Valneva SE
  13.3.1 Valneva SE Company Details
  13.3.2 Valneva SE Business Overview and Its Total Revenue
  13.3.3 Valneva SE Cholera Vaccines Introduction
  13.3.4 Valneva SE Revenue in Cholera Vaccines Business (2015-2020)
  13.3.5 Valneva SE Recent Development
13.4 Merck and Co., Inc.
  13.4.1 Merck and Co., Inc. Company Details
  13.4.2 Merck and Co., Inc. Business Overview and Its Total Revenue
  13.4.3 Merck and Co., Inc. Cholera Vaccines Introduction
  13.4.4 Merck and Co., Inc. Revenue in Cholera Vaccines Business (2015-2020)
  13.4.5 Merck and Co., Inc. Recent Development
13.5 GlaxoSmithKline plc (GSK)
  13.5.1 GlaxoSmithKline plc (GSK) Company Details
  13.5.2 GlaxoSmithKline plc (GSK) Business Overview and Its Total Revenue
  13.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Introduction
  13.5.4 GlaxoSmithKline plc (GSK) Revenue in Cholera Vaccines Business (2015-2020)
  13.5.5 GlaxoSmithKline plc (GSK) Recent Development
13.6 Astellas Pharma, Inc.
  13.6.1 Astellas Pharma, Inc. Company Details
  13.6.2 Astellas Pharma, Inc. Business Overview and Its Total Revenue
  13.6.3 Astellas Pharma, Inc. Cholera Vaccines Introduction
  13.6.4 Astellas Pharma, Inc. Revenue in Cholera Vaccines Business (2015-2020)
  13.6.5 Astellas Pharma, Inc. Recent Development
13.7 Pfizer, Inc.
  13.7.1 Pfizer, Inc. Company Details
  13.7.2 Pfizer, Inc. Business Overview and Its Total Revenue
  13.7.3 Pfizer, Inc. Cholera Vaccines Introduction
  13.7.4 Pfizer, Inc. Revenue in Cholera Vaccines Business (2015-2020)
  13.7.5 Pfizer, Inc. Recent Development
13.8 Emergent BioSolutions, Inc.
  13.8.1 Emergent BioSolutions, Inc. Company Details
  13.8.2 Emergent BioSolutions, Inc. Business Overview and Its Total Revenue
  13.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Introduction
  13.8.4 Emergent BioSolutions, Inc. Revenue in Cholera Vaccines Business (2015-2020)
  13.8.5 Emergent BioSolutions, Inc. Recent Development
13.9 Mitsubishi Tanabe Pharma Corporation
  13.9.1 Mitsubishi Tanabe Pharma Corporation Company Details
  13.9.2 Mitsubishi Tanabe Pharma Corporation Business Overview and Its Total Revenue
  13.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Introduction
  13.9.4 Mitsubishi Tanabe Pharma Corporation Revenue in Cholera Vaccines Business (2015-2020)
  13.9.5 Mitsubishi Tanabe Pharma Corporation Recent Development
13.10 Takeda Pharmaceutical Co., Ltd.
  13.10.1 Takeda Pharmaceutical Co., Ltd. Company Details
  13.10.2 Takeda Pharmaceutical Co., Ltd. Business Overview and Its Total Revenue
  13.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Introduction
  13.10.4 Takeda Pharmaceutical Co., Ltd. Revenue in Cholera Vaccines Business (2015-2020)
  13.10.5 Takeda Pharmaceutical Co., Ltd. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cholera Vaccines Key Market Segments
Table 2. Key Players Covered: Ranking by Cholera Vaccines Revenue
Table 3. Ranking of Global Top Cholera Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cholera Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Dukoral
Table 6. Key Players of Shanchol
Table 7. Key Players of Vaxchora
Table 8. Key Players of Others
Table 9. Global Cholera Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Cholera Vaccines Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Cholera Vaccines Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Cholera Vaccines Market Share by Regions (2015-2020)
Table 13. Global Cholera Vaccines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Cholera Vaccines Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Cholera Vaccines Market Growth Strategy
Table 19. Main Points Interviewed from Key Cholera Vaccines Players
Table 20. Global Cholera Vaccines Revenue by Players (2015-2020) (Million US$)
Table 21. Global Cholera Vaccines Market Share by Players (2015-2020)
Table 22. Global Top Cholera Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholera Vaccines as of 2019)
Table 23. Global Cholera Vaccines by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cholera Vaccines Product Solution and Service
Table 26. Date of Enter into Cholera Vaccines Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cholera Vaccines Market Size by Type (2015-2020) (Million US$)
Table 29. Global Cholera Vaccines Market Size Share by Type (2015-2020)
Table 30. Global Cholera Vaccines Revenue Market Share by Type (2021-2026)
Table 31. Global Cholera Vaccines Market Size Share by Application (2015-2020)
Table 32. Global Cholera Vaccines Market Size by Application (2015-2020) (Million US$)
Table 33. Global Cholera Vaccines Market Size Share by Application (2021-2026)
Table 34. North America Key Players Cholera Vaccines Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Cholera Vaccines Market Share (2019-2020)
Table 36. North America Cholera Vaccines Market Size by Type (2015-2020) (Million US$)
Table 37. North America Cholera Vaccines Market Share by Type (2015-2020)
Table 38. North America Cholera Vaccines Market Size by Application (2015-2020) (Million US$)
Table 39. North America Cholera Vaccines Market Share by Application (2015-2020)
Table 40. Europe Key Players Cholera Vaccines Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Cholera Vaccines Market Share (2019-2020)
Table 42. Europe Cholera Vaccines Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Cholera Vaccines Market Share by Type (2015-2020)
Table 44. Europe Cholera Vaccines Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Cholera Vaccines Market Share by Application (2015-2020)
Table 46. China Key Players Cholera Vaccines Revenue (2019-2020) (Million US$)
Table 47. China Key Players Cholera Vaccines Market Share (2019-2020)
Table 48. China Cholera Vaccines Market Size by Type (2015-2020) (Million US$)
Table 49. China Cholera Vaccines Market Share by Type (2015-2020)
Table 50. China Cholera Vaccines Market Size by Application (2015-2020) (Million US$)
Table 51. China Cholera Vaccines Market Share by Application (2015-2020)
Table 52. Japan Key Players Cholera Vaccines Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Cholera Vaccines Market Share (2019-2020)
Table 54. Japan Cholera Vaccines Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Cholera Vaccines Market Share by Type (2015-2020)
Table 56. Japan Cholera Vaccines Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Cholera Vaccines Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Cholera Vaccines Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Cholera Vaccines Market Share (2019-2020)
Table 60. Southeast Asia Cholera Vaccines Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Cholera Vaccines Market Share by Type (2015-2020)
Table 62. Southeast Asia Cholera Vaccines Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Cholera Vaccines Market Share by Application (2015-2020)
Table 64. India Key Players Cholera Vaccines Revenue (2019-2020) (Million US$)
Table 65. India Key Players Cholera Vaccines Market Share (2019-2020)
Table 66. India Cholera Vaccines Market Size by Type (2015-2020) (Million US$)
Table 67. India Cholera Vaccines Market Share by Type (2015-2020)
Table 68. India Cholera Vaccines Market Size by Application (2015-2020) (Million US$)
Table 69. India Cholera Vaccines Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Cholera Vaccines Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Cholera Vaccines Market Share (2019-2020)
Table 72. Central & South America Cholera Vaccines Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Cholera Vaccines Market Share by Type (2015-2020)
Table 74. Central & South America Cholera Vaccines Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Cholera Vaccines Market Share by Application (2015-2020)
Table 76. Shantha Biotechnics Private Limited Company Details
Table 77. Shantha Biotechnics Private Limited Business Overview
Table 78. Shantha Biotechnics Private Limited Product
Table 79. Shantha Biotechnics Private Limited Revenue in Cholera Vaccines Business (2015-2020) (Million US$)
Table 80. Shantha Biotechnics Private Limited Recent Development
Table 81. PaxVax, Inc. Company Details
Table 82. PaxVax, Inc. Business Overview
Table 83. PaxVax, Inc. Product
Table 84. PaxVax, Inc. Revenue in Cholera Vaccines Business (2015-2020) (Million US$)
Table 85. PaxVax, Inc. Recent Development
Table 86. Valneva SE Company Details
Table 87. Valneva SE Business Overview
Table 88. Valneva SE Product
Table 89. Valneva SE Revenue in Cholera Vaccines Business (2015-2020) (Million US$)
Table 90. Valneva SE Recent Development
Table 91. Merck and Co., Inc. Company Details
Table 92. Merck and Co., Inc. Business Overview
Table 93. Merck and Co., Inc. Product
Table 94. Merck and Co., Inc. Revenue in Cholera Vaccines Business (2015-2020) (Million US$)
Table 95. Merck and Co., Inc. Recent Development
Table 96. GlaxoSmithKline plc (GSK) Company Details
Table 97. GlaxoSmithKline plc (GSK) Business Overview
Table 98. GlaxoSmithKline plc (GSK) Product
Table 99. GlaxoSmithKline plc (GSK) Revenue in Cholera Vaccines Business (2015-2020) (Million US$)
Table 100. GlaxoSmithKline plc (GSK) Recent Development
Table 101. Astellas Pharma, Inc. Company Details
Table 102. Astellas Pharma, Inc. Business Overview
Table 103. Astellas Pharma, Inc. Product
Table 104. Astellas Pharma, Inc. Revenue in Cholera Vaccines Business (2015-2020) (Million US$)
Table 105. Astellas Pharma, Inc. Recent Development
Table 106. Pfizer, Inc. Company Details
Table 107. Pfizer, Inc. Business Overview
Table 108. Pfizer, Inc. Product
Table 109. Pfizer, Inc. Revenue in Cholera Vaccines Business (2015-2020) (Million US$)
Table 110. Pfizer, Inc. Recent Development
Table 111. Emergent BioSolutions, Inc. Business Overview
Table 112. Emergent BioSolutions, Inc. Product
Table 113. Emergent BioSolutions, Inc. Company Details
Table 114. Emergent BioSolutions, Inc. Revenue in Cholera Vaccines Business (2015-2020) (Million US$)
Table 115. Emergent BioSolutions, Inc. Recent Development
Table 116. Mitsubishi Tanabe Pharma Corporation Company Details
Table 117. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 118. Mitsubishi Tanabe Pharma Corporation Product
Table 119. Mitsubishi Tanabe Pharma Corporation Revenue in Cholera Vaccines Business (2015-2020) (Million US$)
Table 120. Mitsubishi Tanabe Pharma Corporation Recent Development
Table 121. Takeda Pharmaceutical Co., Ltd. Company Details
Table 122. Takeda Pharmaceutical Co., Ltd. Business Overview
Table 123. Takeda Pharmaceutical Co., Ltd. Product
Table 124. Takeda Pharmaceutical Co., Ltd. Revenue in Cholera Vaccines Business (2015-2020) (Million US$)
Table 125. Takeda Pharmaceutical Co., Ltd. Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cholera Vaccines Market Share by Type: 2020 VS 2026
Figure 2. Dukoral Features
Figure 3. Shanchol Features
Figure 4. Vaxchora Features
Figure 5. Others Features
Figure 6. Global Cholera Vaccines Market Share by Application: 2020 VS 2026
Figure 7. Oral Case Studies
Figure 8. Others Case Studies
Figure 9. Cholera Vaccines Report Years Considered
Figure 10. Global Cholera Vaccines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Cholera Vaccines Market Share by Regions: 2020 VS 2026
Figure 12. Global Cholera Vaccines Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Cholera Vaccines Market Share by Players in 2019
Figure 15. Global Top Cholera Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholera Vaccines as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Cholera Vaccines Revenue in 2019
Figure 17. North America Cholera Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Cholera Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Cholera Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Cholera Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Cholera Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Cholera Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Cholera Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Shantha Biotechnics Private Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Shantha Biotechnics Private Limited Revenue Growth Rate in Cholera Vaccines Business (2015-2020)
Figure 26. PaxVax, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. PaxVax, Inc. Revenue Growth Rate in Cholera Vaccines Business (2015-2020)
Figure 28. Valneva SE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Valneva SE Revenue Growth Rate in Cholera Vaccines Business (2015-2020)
Figure 30. Merck and Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Merck and Co., Inc. Revenue Growth Rate in Cholera Vaccines Business (2015-2020)
Figure 32. GlaxoSmithKline plc (GSK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline plc (GSK) Revenue Growth Rate in Cholera Vaccines Business (2015-2020)
Figure 34. Astellas Pharma, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Astellas Pharma, Inc. Revenue Growth Rate in Cholera Vaccines Business (2015-2020)
Figure 36. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Pfizer, Inc. Revenue Growth Rate in Cholera Vaccines Business (2015-2020)
Figure 38. Emergent BioSolutions, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Emergent BioSolutions, Inc. Revenue Growth Rate in Cholera Vaccines Business (2015-2020)
Figure 40. Mitsubishi Tanabe Pharma Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Cholera Vaccines Business (2015-2020)
Figure 42. Takeda Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Takeda Pharmaceutical Co., Ltd. Revenue Growth Rate in Cholera Vaccines Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed